A carregar...
Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia
Inhibition of platelet production and mediated by antiplatelet antibodies is a well-known mechanism causing low platelet counts in immune thrombocytopenia (ITP). Use of thrombopoietin receptor agonists increases platelet counts and decreases the risk of bleeding in patients with ITP. Two such thromb...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888762/ https://ncbi.nlm.nih.gov/pubmed/27307776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S80646 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|